ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0590

Molecular Profiling of Normal Human Synovium Reveals Striking Impact of Adipocytes and Homeostatic Cortisol Signaling

Heather Faust1, Tan-Yun Cheng1, Ilya Korsunsky1, Gerald FM Watts1, David Moody1 and Michael Brenner2, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2022

Keywords: corticosteroids, Fibroblasts, Synovial, Inflammation, Osteoarthritis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: The synovium encapsulates joints and contains fibroblasts which proliferate, become invasive, and drive disease progression in rheumatoid arthritis (RA) and osteoarthritis (OA). There is little known regarding normal synovial fibroblasts during homeostasis. Here, we have performed single cell RNA sequencing on healthy synovial tissue from humans.

Methods: Single cell RNA sequencing was performed on synovium from 16 human donors with no diagnosed arthritis, and on adipose tissue from 5 donors. The Bligh and Dyer method was used to fractionate fat conditioned media for lipidomic analysis. Bulk RNA sequencing was performed on cultured synovial fibroblasts. CRISPR-Cas9 was used to delete NR3C1 in synovial fibroblasts. In vitro 2D culture, and 3D synovial organoid culture, were implemented to assess cortisol anti-inflammatory and anti-fibrotic action. Readouts include immunofluorescence, qPCR, and flow cytometry.

Results: Single cell RNA sequencing revealed that healthy synovium is primarily comprised of stromal cells (Fig. 1a-c). We identified a gene expression program which is enriched in homeostatic fibroblasts and characterized by enhanced fatty acid metabolism and lipid transport. The genes APOD, NNMT, and CEBPD, which are related to lipid metabolism were highly expressed in this gene expression program. Since normal synovial fibroblasts are surrounded by adipocytes, we stimulated fibroblasts with fat conditioned media (FCM) and used bulk RNA sequencing to find that the FCM gene signature is significantly enriched in healthy synovial fibroblasts. Through fractionation and lipidomic analysis of fat conditioned media, and validation using NRC31 (the glucocorticoid receptor gene) knockout cells, we discovered that cortisol is the primary factor driving this gene program. (Fig. 2a-b). We performed additional single cell RNA sequencing of adipose tissue fibroblasts. Using the Symphony package to map synovial fibroblasts onto adipose defined fibroblasts, we demonstrated strong mapping to committed preadipocytes. Additionally, committed preadipocytes are enriched in cortisol and FCM gene signatures compared to less committed DPP4+ universal fibroblast progenitors. We further defined the functional roles of cortisol in synovial fibroblast biology. Cortisol suppressed TNFα-induced MMP expression as well as TGFβ-induced fibrotic collagen expression. We found that IFNγ and TGFβ signaling is enhanced in RA and OA fibroblasts compared to normal fibroblasts, and these cytokines dampen cortisol signaling, potentially explaining why cortisol signaling is blunted in arthritis (Fig. 2c).

Conclusion: In sum, healthy synovium is characterized by high cortisol signaling which is also common to adipose tissue fibroblasts and is diminished in OA and RA fibroblasts.

Supporting image 1

Figure 1. H&E staining of synovial tissue sections highlighting broad histological differences among healthy, OA, and RA tissue. B. Synovial cells from healthy, OA, and naïve RA donors were harmonized and clustered into a single UMAP. C. UMAP projection from (B) split by disease state.

Supporting image 2

Figure 2. A. FCM (fat conditioned media) contains cortisol, as measured by mass spectrometry. B. CRISPR cas-9 knockdown of NR3C1, the gene encoding the glucocorticoid receptor, resulted in dramatic reduction of fibroblasts to induce APOD, NNMT, and CEBPD expression in response to FCM. NTC= non-targeting control, GCR= glucocorticoid receptor (NR3C1). C. Cortisol (100nM) was applied to cells along with different cytokines and assessed for APOD, CEBPD, and PLIN2 expression after 24hrs. TGFβ and IFNγ were the only cytokines to significantly impact cortisol signaling.


Disclosures: H. Faust, None; T. Cheng, None; I. Korsunsky, Mestag Therapeutics; G. Watts, None; D. Moody, Enara Bio, Pfizer; M. Brenner, GSK, 4FO Ventures, Mestag Therapeutics.

To cite this abstract in AMA style:

Faust H, Cheng T, Korsunsky I, Watts G, Moody D, Brenner M. Molecular Profiling of Normal Human Synovium Reveals Striking Impact of Adipocytes and Homeostatic Cortisol Signaling [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/molecular-profiling-of-normal-human-synovium-reveals-striking-impact-of-adipocytes-and-homeostatic-cortisol-signaling/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/molecular-profiling-of-normal-human-synovium-reveals-striking-impact-of-adipocytes-and-homeostatic-cortisol-signaling/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology